Avidity Biosciences Inc. is a biotechnology company focused on the development of innovative therapies for unmet medical needs. The primary aim of Avidity is to harness its proprietary Antibody Oligon... Avidity Biosciences Inc. is a biotechnology company focused on the development of innovative therapies for unmet medical needs. The primary aim of Avidity is to harness its proprietary Antibody Oligonucleotide Conjugates (AOCs) platform to create transformative healthcare solutions. This platform combines antibodies and oligonucleotides to precisely target and deliver therapeutic payloads to specific diseased cells, potentially advancing treatments for a range of genetic disorders. The company's research primarily impacts sectors such as rare disease treatment and genetic medicine, where precision and efficacy are critical. By leveraging its unique technology, Avidity Biosciences plays a significant role in the biotechnology landscape, fostering advancements that seek to alter the genetic disease treatment paradigm and improve patient outcomes globally.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Avidity Biosciences is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Avidity Biosciences is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Avidity Biosciences's data?

Create a free Tracenable account to signal interest in having our team review data for Avidity Biosciences.

Legal Center Contact Us